Maria Wiśniewska‐Jarosińska

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Séverine Vermeire, Stefan Schreiber, Robert Petryka et al. · The Lancet · 2016 · 439 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer—a case control study

Renata Krupa, Tomasz Śliwiński, Maria Wiśniewska‐Jarosińska et al. · Molecular Biology Reports · 2010 · 87 citations · Full text

Medicine, Genetics, Oncology +17

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11

Independent and combined cytotoxicity and genotoxicity of triethylene glycol dimethacrylate and urethane dimethacrylate

Maria Wiśniewska‐Jarosińska, Tomasz Popławski, Cezary Chojnacki et al. · Molecular Biology Reports · 2010 · 72 citations · Full text

Dentistry, Dental Materials Science, Dental Materials +12

Zinc salts differentially modulate DNA damage in normal and cancer cells

Tomasz Śliwiński, Agnieszka Czechowska, Magdalena Kolodziejczak et al. · Cell Biology International · 2009 · 72 citations

Medicine, Cell Biology, Oncology +17